NCT07450989

Brief Summary

This study aims to evaluate the impact of assistive torque from a hip-assist exoskeleton on gait patterns in healthy adults. The investigators will analyze how different torque settings affect spatiotemporal parameters, joint kinematics, muscle activity (EMG), and foot pressure during walking.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable healthy-volunteers

Timeline
Completed

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

Same day

First QC Date

January 14, 2026

Last Update Submit

March 3, 2026

Conditions

Outcome Measures

Primary Outcomes (8)

  • Step Length

    Distance between the point of initial contact of one foot and the point of initial contact of the opposite foot. Unit: Meters (m)

    Day 1

  • Stride Length

    Distance between successive points of initial contact of the same foot. Unit: Meters (m)

    Day 1

  • Cadence

    Number of steps taken per minute. Unit: steps/min

    Day 1

  • Gait Speed

    verage walking speed during the 10-meter walk test. Unit: Meters per second (m/s)

    Day 1

  • Single/Double Limb Support Phase

    The duration of time when one or both feet are in contact with the ground. Unit: Percentage of gait cycle (% GC)

    Day 1

  • Hip Joint Range of Motion

    The maximum excursion of the hip joint in the sagittal plane during the gait cycle. Unit: Degrees

    Day 1

  • Knee Joint Range of Motion

    The maximum excursion of the knee joint in the sagittal plane during the gait cycle. Unit: Degrees

    Day 1

  • Ankle Joint Range of Motion

    The maximum excursion of the ankle joint in the sagittal plane during the gait cycle. Unit: Degrees

    Day 1

Secondary Outcomes (7)

  • Muscle Activation of Rectus Femoris

    Day 1

  • Muscle Activation of Vastus Medialis

    Unit: Microvolts

  • Muscle Activation of Medial Hamstring

    Day 1

  • Muscle Activation of Tibialis Anterior

    Day 1

  • Muscle Activation of Gastrocnemius

    Day 1

  • +2 more secondary outcomes

Study Arms (1)

Healthy Adult Group

EXPERIMENTAL

Healthy adult males and females aged 19 years or older, with a body weight ranging from 50 kg to 100 kg, who meet all inclusion criteria and have no history of hip surgery or gait impairment.

Device: ANGEL SUIT H10 (Hip-assist exoskeleton)

Interventions

A wearable robot that provides assistive torque (Flexion/Extension) to the hip joint during walking.

Healthy Adult Group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults aged 19 years or older without gait impairment.
  • Body weight between 50kg and 100kg.
  • No history of hip surgery.
  • Capable of wearing a hip-assist exoskeleton.
  • Voluntarily signed the informed consent form.

You may not qualify if:

  • Skin or musculoskeletal issues that prevent wearing the exoskeleton.
  • Inability to walk independently while wearing the exoskeleton.
  • Other conditions deemed inappropriate by the investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Severance Hospital

Seoul, 03722, South Korea

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2026

First Posted

March 5, 2026

Study Start

March 1, 2026

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

March 5, 2026

Record last verified: 2026-03

Locations